rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
12
|
pubmed:dateCreated |
2001-1-25
|
pubmed:abstractText |
Barrett esophagus (BE) is a premalignant condition resulting from chronic acid gastroesophageal reflux and is associated with increased epithelial cell proliferation. Elimination of acid reflux might decrease cancer risk by affecting cell proliferation in BE. The effect of elimination of acid reflux on epithelial cell proliferation in BE was studied.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Dec
|
pubmed:issn |
0036-5521
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
35
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1238-44
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11199360-Adult,
pubmed-meshheading:11199360-Aged,
pubmed-meshheading:11199360-Barrett Esophagus,
pubmed-meshheading:11199360-Biopsy,
pubmed-meshheading:11199360-Cell Division,
pubmed-meshheading:11199360-Double-Blind Method,
pubmed-meshheading:11199360-Enzyme Inhibitors,
pubmed-meshheading:11199360-Gastric Mucosa,
pubmed-meshheading:11199360-Gastroesophageal Reflux,
pubmed-meshheading:11199360-Histamine H2 Antagonists,
pubmed-meshheading:11199360-Humans,
pubmed-meshheading:11199360-Hydrogen-Ion Concentration,
pubmed-meshheading:11199360-Immunohistochemistry,
pubmed-meshheading:11199360-Middle Aged,
pubmed-meshheading:11199360-Omeprazole,
pubmed-meshheading:11199360-Prospective Studies,
pubmed-meshheading:11199360-Ranitidine,
pubmed-meshheading:11199360-Statistics, Nonparametric
|
pubmed:year |
2000
|
pubmed:articleTitle |
Effect of elimination of acid reflux on epithelial cell proliferative activity of Barrett esophagus.
|
pubmed:affiliation |
Dept of Gastroenterology and Hepatology, University Hospital, Groningen, The Netherlands.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't
|